Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

304 Press Releases
DateTitleCompany
26 Mar 15 ABPI and BIA welcome the MMIP’s successful campaign to get funding for exciting new manufacturing design processes project ABPI,
Published by
PharmiWeb.com
26 Mar 15 PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership in Pharmacovigilance Services PAREXEL,
Published by
PharmiWeb.com
26 Mar 15 Dolomite’s microfluidics technology ideal for B cell encapsulation Dolomite
26 Mar 15 ICECHIM invests in flow chemistry with the Syrris Asia system Syrris Ltd
26 Mar 15 Lyophilized Injectables Growth at Fourteen Percent as Biologicals Proliferate Greystone Research Associates
26 Mar 15 Approval of Antiviral Drug, Copegus® for Additional Indication Chugai Pharmaceutical Co., Ltd
26 Mar 15 Medical breakthroughs on the horizon with £32m boost for UK research MRC
26 Mar 15 BUPA STARTUP STAGE SPEAKERS ANNOUNCED FOR WIRED HEALTH WIRED Health 2015
26 Mar 15 ENCORE Clinical Data Published in The Lancet Suggest Treatment with Oral Maintenance Therapy Effective in Previously Treated Gaucher Disease Patients Genzyme
26 Mar 15 Colli-PeeTM by Novosanis nominated for IWT Innovation Award Novosanis
26 Mar 15 Phosphagenics signs license agreement to expand TPM®-based animal nutrition products to the UK and Ireland Phosphagenics Limited
26 Mar 15 Cancer Research UK and Medidata Partner to Streamline Data Collection and Management for Cancer Clinical Trials Cancer Research UK
26 Mar 15 EISAI RECEIVES APPROVAL IN JAPAN FOR ANTICANCER AGENT LENVIMA® (LENVATINIB MESYLATE) AS TREATMENT FOR UNRESECTABLE THYROID CANCER EISAI,
Published by
PharmiWeb.com
26 Mar 15 Otsuka Granted Approval in Japan for a New Formulation of ABIILIFY – ABILIFY for Extended–release Injectable Suspension, for Intramuscular Use – Indicated for Schizophrenia Otsuka,
Published by
PharmiWeb.com
25 Mar 15 Announcement Regarding Closure of Merger Between Daiichi Sankyo Subsidiary Ranbaxy and Sun Pharma More: http://www.pharmiweb.com/#ixzz3VNjlR49Q PharmiWeb 2002 Ltd,
Published by
PharmiWeb.com
25 Mar 15 ASTELLAS AND MEDIVATION ANNOUNCE NEW ENZALUTAMIDE DATA PRESENTED DURING PLENARY PRESENTATIONS AT THE 2015 EUROPEAN ASSOCIATION OF UROLOGY CONGRESS ASTELLAS, MEDIVATION,
Published by
PharmiWeb.com
25 Mar 15 AstraZeneca to collaborate with the Harvard Stem Cell Institute in diabetes AstraZeneca,
Published by
PharmiWeb.com
24 Mar 15 GSK’s 2015 Discovery Fast Track Challenge seeks early drug discovery partnerships with academics in Europe, Canada and US GSK,
Published by
PharmiWeb.com
24 Mar 15 Pfizer Invites Public To View And Listen To Webcast Of April 28 Conference Call With Analysts Pfizer,
Published by
PharmiWeb.com
24 Mar 15 Alnylam Initiates ENDEAVOUR Phase 3 Clinical Trial with Revusiran Richmond Pharmacology enrols first patient worldwide Richmond Pharmacology, Alnylam,
Published by
PharmiWeb.com
24 Mar 15 11 leading pharma companies, including AbbVie, Sanofi, Beroe, Pfizer, Fresenius Kabi, AstraZeneca, GSK, Sandoz, will meet in Iselin this April at Pre-Filled Syringes North America 2015 SMi Group
24 Mar 15 Pfizer And Lilly Preparing To Resume Phase 3 Chronic Pain Program For Tanezumab Pfizer Inc
24 Mar 15 Bayer Furthers Global Efforts to Lead Fight Against Vector-Borne Diseases Bayer HealthCare
24 Mar 15 Takeda Licenses Rights to Use ImmunoGen, Inc.'s Novel Antibody-Drug Conjugate Technology Takeda, ImmunoGen,
Published by
PharmiWeb.com
23 Mar 15 IPSEN IN THE UK ANNOUNCES NAME CHANGE FOR ITS UK-BASED LIFE SCIENCES COMPANY FROM SYNTAXIN TO IPSEN BIOINNOVATION Ipsen
23 Mar 15 Huntingdon Life Sciences and Harlan Laboratories announce joint presence at SOT 2015 Huntingdon Life Science and Harlan Laboratories,
Published by
De Facto
23 Mar 15 2015 ASTELLAS EUROPEAN FOUNDATION FUNCTIONAL UROLOGY/URO-GYNAECOLOGY GRANT TO LOOK AT BRAIN ACTIVATION PATTERNS OF BLADDER ACTIVITY DISORDER PATIENTS Astellas European Foundation,
Published by
Astellas
23 Mar 15 ACTELION ANNOUNCES COMMENCEMENT OF SHARE REPURCHASE PROGRAM ACTELION,
Published by
PharmiWeb.com
23 Mar 15 Novartis' Cosentyx(TM) two-year data shows sustained effect and favorable safety profile in psoriasis patients Novartis,
Published by
PharmiWeb.com
23 Mar 15 New Novartis data shows Cosentyx(TM) is significantly superior to Stelara® and clears skin (PASI 90) in nearly 80% of psoriasis patients Novartis,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.